Best TrueBeam doctors: TOP 15 doctors

Mustafa Solak, M.D. is a medical doctor who graduated from Hacettepe University School of Medicine and has completed residencies at Istanbul Sisli Etfal Teaching and Research Hospital and a fellowship at Hacettepe University Cancer Institute. He specializes in Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head-Neck Cancer, and Gastrointestinal Cancers. He has also worked at the University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.

Dr. Ofer Merimsly is the best sarcoma, lymphoma, and lung cancer doctor within Israel and in the world. Also specializes in Whipple surgery treatment for patients with pancreatic cancer. Head of the National Center for sarcomas of bone and soft tissues of the Tel Aviv Medical Center Sourasky (Ichilov).

Specialty:

• Treatment of all types of lung cancer and thoracic organs
• Treatment of all types of sarcomas of bone and soft tissue
• Treatment stromal tumors of the gastrointestinal tract

Education and specialization:

• Higher medical education, graduated the Medical Faculty of the Hebrew University of Jerusalem, Israel
• Residency in General Oncology and Radiotherapy
• Training in the field of radiotherapy and brachytherapy at New York Hospital, USA
• Special refresher course for the treatment of tumors of the skeleton and soft tissues, Paris. France

Membership:

• President of the Society of oncologists and radiotherapists Israel
• The American Scientific Cancer Society
• European scientific medical organization
• European Society of Oncology of the musculoskeletal system
• International Society for the treatment of tumors of the connective tissue

Dr. Raj is a highly experienced Surgical Oncologist with 19 years of experience and over 50,000 cancer surgeries performed. He is involved in numerous clinical trials and has many international and national publications to his credit. He specializes in Breast and Thoracic Surgical Oncology and serves as a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at the Maharashtra University of Health Sciences. His belief is in "adding life to years" and improving the quality of life, not just adding years to life.

Director of Radiotherapy Institute Oncology Division

Education/Residency:

• Completed residency in general oncology and radiotherapy (radiation therapy) at Sheba Hospital, Tel Hashomer.
• During her work, she gained extensive experience in treating tumors of the female reproductive system and is currently a coordinator for the treatment of patients suffering from these diseases.
• Fellowship - Anderson Cancer Center, Houston, Texas - 2012-2014

Dr. Tatyana Rabin's research interests include:

Methods of destruction of malignant neoplasms by heating with the help of ultrasonic waves, research into the use of brachytherapy in the treatment of oncogynecological diseases,

study of the mechanisms of response at the molecular level of prostate tumor cells to radiotherapy;

clinical studies of oncomammology, oncopulmonology, ocular lymphoma.

Dr. Rabin is investigating the molecular mechanisms by which prostate cancer cells respond to radiation therapy. This research is being conducted in collaboration with the Weizmann Institute of Science.

In addition, Dr. Rabin has been involved in clinical research in the areas of breast cancer, lung cancer, and ocular lymphoma.

Dr. Rabin is currently coordinating a new and unique study at Sheba Hospital that is investigating a method of treating cancerous tumors using MRI-guided ultrasound waves. This method involves raising the tumor's temperature to a certain level and then destroying it.

Awards:

Dr. Tatyana Rabin was recognized as the best hospital employee for 2007.

Experience and participation in scientific research:

• Scientific research in the field of gynecological oncology
• Scientific research in the field of lung tumors
• Application of brachytherapy in oncogynecology
• SBRT techniques in the treatment of tumors of the respiratory system
• Study of molecular mechanisms of prostate tumor cell response to radiation therapy. This study was organized in collaboration with the laboratory of the H. Weizmann Institute.
• In addition, Dr. Rabin has been involved in clinical research in the areas of breast cancer, lung cancer, and ocular lymphoma.

Membership in medical societies :

• Israel Society of Oncology and Clinical Radiotherapy (ISCORT) American Society of Radiology and Oncology (ASTRO)
• Israel Association of Palliative Medicine

Dr. Lalit is a highly experienced oncological surgeon with 10 years of experience and over 10,000 major surgeries performed. He has done his MBBS from MIMER, Pune and MS from GMC Panaji. He has fellowship in Surgical Oncology and worked as a Co-principal Investigator in multiple original research. He is known for his patient friendly and ethical approach, and his main interest is in Minimal Invasive Cancer Surgeries.

Education and Career

2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

Medicine Department of Internal Medicine

2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

Memberships in Scientific Organizations

ASCO

ESMO

TTOD 

AVOD 

Publications

In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

Awards Received

EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

Speeches Delivered at National Congresses, Conferences, and Symposia:

Courses, Meetings, and Certificates

ESMO certified Medical Oncologist since 2019

Education

• (2004 – 2011), Faculty of Medicine/ Inonu University/ Malatya, Turkiye
• (2011 – 2015), Department of Radiology/ Bagcilar Training and Research Hospital/ Istanbul, Turkiye

Career

• (2016 – 2020), Diagnostic and Interventional Radiologist/ Mus State Hospital/ Mus,Turkiye
• (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology/ Sakarya University Training and Research Hospital/ Sakarya, Turkiye
• (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology /Sakarya University Training and Research Hospital/ Sakarya, Turkiye
• (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology /Medipol University Hospital/ Istanbul, Turkiye

Prof. Dr. med. Volker Budach *Prof. Dr.med. Volker Budach

He completed his medical studies at the University of Essen and was appointed to the Department of Radiotherapy at the Charité Hospital in Berlin in 1993. He successfully headed this department until 2022, with almost 40 years of professional and 30 years of managerial experience. Under the direction of Prof. Dr. Budach, numerous clinical studies were conducted, especially in the therapy of head and neck tumors. Along with other tumors such as sarcomas, bronchial carcinomas and breast carcinomas, which are his clinical and scientific focus. Prof. Dr. Budach founded and for many years jointly directed the comprehensive cancer center at the Charité. In addition to his function as director of the clinic, he also headed the Charité Center 14, which combined the topics of imaging and oncology. Prof. Budach was President of the German Society for Radiation Oncology (DEGRO) and President of its congress. At the EORTC, he headed the head and neck tumour group for many years. He is the author of numerous important papers on the optimisation of radiotherapy and chemotherapy in the treatment of head and neck tumours. After 30 years of leading the clinic, Prof. Dr. Budach decided to transfer his experience in radiation oncology to the RadioOnkologie Vosspalais clinic. Prof. Dr. Budach is a member of the professional associations DEGRO, ESTRO, ASTRO.

Known Expertise 

Medical Oncologist 

Academic Position 

Senior Lecturer 

Education

Bar-Ilan University, Israel / Computational Biology 

Israeli Society for Health-Tech / Fellowship by IMA/ Innovation and Entrepreneurship in Medicine and Health-Tech 

Sheba Medical Center and Bar-Ilan University, Israel/ Genomics and Biomedical Informatics 

Semmelweis University/Doctor of Medicine 

Training and Specialization 

Clinical observership in acute oncology, early phase clinical trials and lung cancer/ Guy's and St. Thomas hospital, London, England 

Leader Shift, Executive Development Program, Tel-Aviv Sourasky Medical Center 

Fellowship Program in Innovation and Entrepreneurship in Medicine and Health-Tech 

Resident, Medical Oncology, TASMC, Israel 

6th year medical school rotations, Kaplan Medical Center, Israel 

Rotation, intensive care unit and pulmonology, Stony Brook hospital, NY, US 

Clinical Experience 

Leader of the TASMC oncology project of PSIFAS, the Israeli National Genomic Medicine Initiative 

PI for study initiator trial: T-Cell Repertoire sequencing as clinical efficacy tool for pembrolizumab (with platinum based chemotherapy) in advanced NSCLC. 

PI for study initiator trial: T-cell repertoire sequencing as a clinically efficacy tool for neoadjuvant immunotherapy plus platinum-doublet chemotherapy for resectable NSCLC. 

Representative of the National Medical Association for the National Council for the Prevention, Diagnosis and Treatment of Malignant Diseases, as well as head of the oncology field, Leumit HMO 

Consultant on drugs and operations in the field of oncology, Leumit HMO 

Member of the Helsinki Committee for Clinical Studies, TASMC 

Primary investigator (PI) in pharmaceutical phases I&III clinical trials Head of oncology day-care service, TASMC, Israel 

Molecular Tumor Board (MTB) moderator of the Israeli Lung Cancer Society 

NGS interpretation clinic alongside head of pathology, TASMC, Israel 

PI for study initiator trial: Genomic Variant of BCL-2 as a Novel Predictor of Response to Paclitaxel, TASMC, Israel 

Medical oncology clinic in the field of lung and breast cancer, TASMC, Israel

Leading sub-investigator (SI) in many phase I-III clinical trials in oncology, including intra-tumoral injections (mRNA, viruses and NO), TASMC, Israel 

Courses 

Good Clinical Practice ICH GCP R2 & Israeli MOH Guidelines Updated Course 

Point-of-Care Ultrasound course, Israeli Medical Association 

GCP training Bioforum 

GCP training Bioforum

Investigator Site Personnel ICH GCP Training Certificate - TransCelerate BioPharma 

Academic Experience 

Lecturer in the Department of Medical Education at the Faculty of Medical and Health Sciences at Tel Aviv University 

JIMS Journal Club - Instructor for students. 

Guidance of Dr. Aviv Berkovich M.D in basic science: cfDNA NGS for identification ofprimary and acquired resistance in patients with Lung Cancer and EGFR mutations. 

TASMC, Israel in collaboration with The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, NY USA 

Training team for oncology residents, TASMC, Israel 

Mentor for new intern, TASMC, Israel 

Tutor for medical students in oncology clerkships, Tel-Aviv University, Israel 

Honors 

Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel

 Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel 

Sign of honor for reserve medical personnel for the battle in Lebanon, IDF

Completion of residency final examination (shlav Beit) with honors 

Israeli society for clinical oncology and radiation therapy (ISCORT) 17 research grant competition winner 

Affiliations 

Israeli Medical Association (IMA) 

Israeli Society for Clinical Oncology and Radiation Therapy (ISCORT) 

The Israeli Lung Cancer Group (ILCG) 

European Society of Medical Oncology (ESMO) 

International Association for the Study of Lung Cancer (IASLC) 

The International Society of Liquid Biopsy (ISLB) 

The Israeli Society for Health-Tech 

Boards 

Co-founder, board member and treasurer of the Israeli Acute Oncology Society 

Clinical Research Association Board of Directors on behalf of the Israeli Lung Cancer Group 

Member of the Trustees of Oncology Innovation, TASMC, Israel 

Doctor of Medical Service IDF 

Areas of interest 

Thoracic malignancies, 

early to late phase clinical trials, 

intra-tumoral injections, 

comprehensive genomic profiling of tumors, 

liquid biopsies: cfDNA, TCR rep-seq and epi-Genetics; 

cell therapy

Education:

• 2008 – 2012: Marmara University School of Medicine (Specialization Training)
• 1998 – 2005: Istanbul University Cerrahpaşa School of Medicine

Work Experience:

• 2012 – Present: Neolife Medical Center

Memberships:

• Turkish Society of Radiation Oncology

Scientific Works:

2014:

• 11th National Radiation Oncology Congress
  • Oral Presentation: "Late-stage kidney damage after chemoradiotherapy in gastric cancer patients, clinical, functional, and dosimetric examination of tolerance doses."
  • Poster Presentation: "Early-stage stereotactic radiotherapy results in lung metastases."

2011:

• 1st Evidence-Based Medicine Course
  • "Evaluation of late side effects in patients treated with conformal radiotherapy for localized prostate cancer: A TOG Side Effects Subgroup Study."

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital